|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.22 USD | -1.83% |
|
-1.69% | +49.61% |
| Feb. 04 | PAVmed Inc. announced that it has received $30 million in funding | CI |
| Feb. 02 | PAVmed Inc. announced that it expects to receive $30 million in funding | CI |
| Capitalization | 14.88M 12.86M 11.65M 11.18M 20.4M 1.37B 21.3M 138M 55.07M 654M 55.83M 54.64M 2.35B | P/E ratio 2025 * |
-2.89x | P/E ratio 2026 * | -0.43x |
|---|---|---|---|---|---|
| Enterprise value | 14.88M 12.86M 11.65M 11.18M 20.4M 1.37B 21.3M 138M 55.07M 654M 55.83M 54.64M 2.35B | EV / Sales 2025 * |
-
| EV / Sales 2026 * | 29.8x |
| Free-Float |
90.91% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: PAVmed Inc.
| 1 day | -1.83% | ||
| 1 week | -1.69% | ||
| Current month | -1.69% | ||
| 1 month | -8.24% | ||
| 3 months | -4.69% | ||
| 6 months | -22.98% | ||
| Current year | +49.61% |
| 1 week | 9.3 | 10.63 | |
| 1 month | 8.43 | 11.34 | |
| Current year | 6 | 28.44 | |
| 1 year | 6 | 28.44 | |
| 3 years | 6 | 280.91 | |
| 5 years | 6 | 4,365 | |
| 10 years | 6 | 6,858 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian deGuzman
CMP | Compliance Officer | 62 | 2023-03-31 |
Lishan Aklog
CEO | Chief Executive Officer | 60 | 2014-06-25 |
Dennis McGrath
DFI | Director of Finance/CFO | 69 | 2017-03-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Glennon
BRD | Director/Board Member | 60 | 2014-09-30 |
Lishan Aklog
CHM | Chairman | 60 | 2014-06-25 |
Ronald Sparks
BRD | Director/Board Member | 71 | 2014-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.83% | -1.69% | -50.70% | -95.36% | 14.88M | ||
| -2.79% | -2.31% | -3.52% | -8.85% | 193B | ||
| -3.29% | -4.30% | -10.53% | +105.18% | 176B | ||
| -2.25% | -5.90% | -7.73% | -20.67% | 143B | ||
| -2.05% | -5.98% | -28.32% | +51.35% | 108B | ||
| +0.07% | -3.87% | -23.13% | -20.00% | 52.25B | ||
| -3.40% | -5.47% | +13.84% | +3.73% | 48.72B | ||
| -2.05% | -2.62% | +10.90% | +13.87% | 37.19B | ||
| -3.03% | -11.13% | -12.32% | -2.33% | 35.14B | ||
| -2.02% | -4.64% | -8.53% | -19.19% | 33.38B | ||
| Average | -2.17% | -1.74% | -12.00% | +0.77% | 82.7B | |
| Weighted average by Cap. | -2.42% | -1.88% | -9.13% | +22.23% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | 500K 432K 392K 376K 686K 45.92M 716K 4.63M 1.85M 22M 1.88M 1.84M 78.89M |
| Net income | -7.1M -6.14M -5.56M -5.34M -9.74M -652M -10.17M -65.78M -26.29M -312M -26.65M -26.08M -1.12B | -20.4M -17.64M -15.98M -15.34M -27.97M -1.87B -29.21M -189M -75.52M -898M -76.57M -74.93M -3.22B |
| Net Debt | - | - |
Employees
39
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-06 | 9.910 $ | -4.80% | 1,124 |
| 26-03-05 | 10.41 $ | -0.86% | 17,471 |
| 26-03-04 | 10.50 $ | +3.45% | 40,981 |
| 26-03-03 | 10.15 $ | +0.89% | 36,962 |
| 26-03-02 | 10.06 $ | -0.20% | 8,408 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.41USD
Average target price
510.00USD
Spread / Average Target
+4,799.14%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PAVM Stock
Select your edition
All financial news and data tailored to specific country editions

















